Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Naltrexone and Bupropion Combination on Weight Loss and Smoking Cessation in Obese, Cigarette-smoking Patients With Schizophrenia

NCT02736474 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT02736474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02736474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Naltrexone and Bupropion Combination on Weight Loss and Smoking Cessation in Obese, Cigarette-smoking Patients With Schizophrenia
Lead sponsor
Shanghai Mental Health Center
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2016
Completion date
July 31, 2018
Enrollment
22 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cigarette-smoking, obese, schizophrenia